185 related articles for article (PubMed ID: 15051407)
1. Immunogenicity of the histidine-to-tyrosine staphylococcal enterotoxin B mutant protein in C3H/HeJ mice.
Savransky V; Pinelis D; Korolev S; Ionin B; Fegeding K
Toxicon; 2004 Mar; 43(4):433-8. PubMed ID: 15051407
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcal enterotoxin B mutants (N23K and F44S): biological effects and vaccine potential in a mouse model.
Woody MA; Krakauer T; Stiles BG
Vaccine; 1997 Feb; 15(2):133-9. PubMed ID: 9066029
[TBL] [Abstract][Full Text] [Related]
3. Central roles for IL-2 and MCP-1 following intranasal exposure to SEB: a new mouse model.
Huzella LM; Buckley MJ; Alves DA; Stiles BG; Krakauer T
Res Vet Sci; 2009 Apr; 86(2):241-7. PubMed ID: 18793785
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcal enterotoxin B induces hepatic injury and lethal shock in endotoxin-resistant C3H/HeJ mice despite a deficient macrophage response.
Yasuda S; Nagaki M; Moriwaki H
J Endotoxin Res; 2002; 8(4):253-61. PubMed ID: 12230915
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcal cell membrane antigen, a possible antigen in post-methicillin resistant Staphylococcus aureus (MRSA) infection nephritis and IgA nephropathy, exhibits high immunogenic activity that is enhanced by superantigen.
Shimizu Y; Sakurai H; Hirayama K; Seki M; Yoh K; Yamagata K; Koyama A
J Nephrol; 2005; 18(3):249-56. PubMed ID: 16013011
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and efficacy against lethal aerosol staphylococcal enterotoxin B challenge in monkeys by intramuscular and respiratory delivery of proteosome-toxoid vaccines.
Lowell GH; Colleton C; Frost D; Kaminski RW; Hughes M; Hatch J; Hooper C; Estep J; Pitt L; Topper M; Hunt RE; Baker W; Baze WB
Infect Immun; 1996 Nov; 64(11):4686-93. PubMed ID: 8890226
[TBL] [Abstract][Full Text] [Related]
7. Natural killer T cells are required for the development of a superantigen-driven T helper type 2 immune response in mice.
Nomizo A; Postol E; de Alencar R; Cardillo F; Mengel J
Immunology; 2005 Oct; 116(2):233-44. PubMed ID: 16162272
[TBL] [Abstract][Full Text] [Related]
8. Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax.
Chen WH; Pasetti MF; Adhikari RP; Baughman H; Douglas R; El-Khorazaty J; Greenberg N; Holtsberg FW; Liao GC; Reymann MK; Wang X; Warfield KL; Aman MJ
Clin Vaccine Immunol; 2016 Dec; 23(12):918-925. PubMed ID: 27707765
[TBL] [Abstract][Full Text] [Related]
9. Acute systemic immune activation following vaginal exposure to staphylococcal enterotoxin B--implications for menstrual shock.
Rajagopalan G; Smart MK; Murali N; Patel R; David CS
J Reprod Immunol; 2007 Feb; 73(1):51-9. PubMed ID: 17070600
[TBL] [Abstract][Full Text] [Related]
10. Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigens.
Bavari S; Ulrich RG; LeClaire RD
J Infect Dis; 1999 Oct; 180(4):1365-9. PubMed ID: 10479174
[TBL] [Abstract][Full Text] [Related]
11. Toxicity of the staphylococcal enterotoxin B mutants with histidine-to-tyrosine substitutions.
Korolev S; Pinelis D; Savransky V; Komisar J; Vogel P; Fegeding K
Toxicology; 2003 May; 187(2-3):229-38. PubMed ID: 12699911
[TBL] [Abstract][Full Text] [Related]
12. A novel staphylococcal enterotoxin B subunit vaccine candidate elicits protective immune response in a mouse model.
Choi JY; Shin S; Kim NY; Son WS; Kang TJ; Song DH; Yu CH; Hur GH; Jeong ST; Shin YK
Toxicon; 2017 Jun; 131():68-77. PubMed ID: 28359755
[TBL] [Abstract][Full Text] [Related]
13. Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model.
Stiles BG; Garza AR; Ulrich RG; Boles JW
Infect Immun; 2001 Apr; 69(4):2031-6. PubMed ID: 11254555
[TBL] [Abstract][Full Text] [Related]
14. Immunization with a nontoxic mutant of staphylococcal enterotoxin A, SEAD227A, protects against enterotoxin-induced emesis in house musk shrews.
Hu DL; Omoe K; Sashinami H; Shinagawa K; Nakane A
J Infect Dis; 2009 Feb; 199(3):302-10. PubMed ID: 19133806
[TBL] [Abstract][Full Text] [Related]
15. Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice.
Lowell GH; Kaminski RW; Grate S; Hunt RE; Charney C; Zimmer S; Colleton C
Infect Immun; 1996 May; 64(5):1706-13. PubMed ID: 8613381
[TBL] [Abstract][Full Text] [Related]
16. Immunization with glutathione S-transferase and mutant toxic shock syndrome toxin 1 fusion protein protects against Staphylococcus aureus infection.
Cui JC; Hu DL; Lin YC; Qian AD; Nakane A
FEMS Immunol Med Microbiol; 2005 Jul; 45(1):45-51. PubMed ID: 15985222
[TBL] [Abstract][Full Text] [Related]
17. Oral vaccine formulations stimulate mucosal and systemic antibody responses against staphylococcal enterotoxin B in a piglet model.
Inskeep TK; Stahl C; Odle J; Oakes J; Hudson L; Bost KL; Piller KJ
Clin Vaccine Immunol; 2010 Aug; 17(8):1163-9. PubMed ID: 20554806
[TBL] [Abstract][Full Text] [Related]
18. B cell epitope mapping of the bacterial superantigen staphylococcal enterotoxin B: the dominant epitope region recognized by intravenous IgG.
Nishi JI; Kanekura S; Takei S; Kitajima I; Nakajima T; Wahid MR; Masuda K; Yoshinaga M; Maruyama I; Miyata K
J Immunol; 1997 Jan; 158(1):247-54. PubMed ID: 8977196
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against superantigenic exotoxins produced by Staphylococcus aureus in sera from mothers and their infants' cord blood.
Takahashi N; Hattori M; Miwa K; Nishida H
Am J Perinatol; 2006 Oct; 23(7):413-9. PubMed ID: 17004199
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1.
Kum WW; Chow AW
J Infect Dis; 2001 Jun; 183(12):1739-48. PubMed ID: 11372026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
